Cargando…

Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review

Cervical cancer is the fourth most common malignant tumor globally in terms of morbidity and mortality. The presence of lymph node metastasis (LNM) is an independent prognostic factor for progression-free survival (PFS) and overall survival (OS) in cervical cancer patients. The International Federat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Fengying, Pang, Huiting, Yu, Tao, Luo, Yahong, Dong, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966198/ https://www.ncbi.nlm.nih.gov/pubmed/35341413 http://dx.doi.org/10.1177/15330338221086403

Ejemplares similares

Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
por: Ye, Yanna, et al.
Publicado: (2023)

Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer
por: Long, Xingtao, et al.
Publicado: (2023)

A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14‐year multicenter study
por: Ye, Yanna, et al.
Publicado: (2023)

Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study
por: Li, Zhiqiang, et al.
Publicado: (2022)

Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study
por: Duan, Hui, et al.
Publicado: (2023)

Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer
por: Chang, Hong, et al.
Publicado: (2023)

Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study
por: Kagabu, Masahiro, et al.
Publicado: (2021)

A comprehensive analysis of the factors of positive pelvic lymph nodes on survival of cervical cancer patients with 2018 FIGO stage IIIC1p
por: Yan, Ding-Ding, et al.
Publicado: (2019)

Reviewing FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2023)

Pretreatment [(18)F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1
por: Burchardt, Ewa, et al.
Publicado: (2021)

Critical analysis of the FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2022)

Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors
por: Yan, Ding-Ding, et al.
Publicado: (2019)

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
por: Rutten, Marianne J., et al.
Publicado: (2015)

Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018)
por: Chen, Xiaolin, et al.
Publicado: (2022)

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
por: Kuhn, W, et al.
Publicado: (1999)

Image-guided intensity-modulated radiotherapy in patients with FIGO IIIC1 cervical cancer: efficacy, toxicity and prognosis
por: Meng, Qingyu, et al.
Publicado: (2023)

Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer
por: Aigner, Karl R., et al.
Publicado: (2021)

Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer
por: Wagner-Larsen, Kari S., et al.
Publicado: (2022)

Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery
por: Fan, Xiang, et al.
Publicado: (2023)

Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
por: Zang, Lele, et al.
Publicado: (2021)

Implications of the revised cervical cancer FIGO staging system
por: Bhatla, Neerja, et al.
Publicado: (2021)

Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system
por: Machida, Hiroko, et al.
Publicado: (2022)

Does the New FIGO 2018 Staging System Allow Better Prognostic Differentiation in Early Stage Cervical Cancer? A Dutch Nationwide Cohort Study
por: Ten Eikelder, Mieke L. G., et al.
Publicado: (2022)

Curative treatment for stage IIIC2 cervical cancer: what to expect?
por: Mauro, Geovanne Pedro, et al.
Publicado: (2023)

Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
por: Pedone Anchora, Luigi, et al.
Publicado: (2020)

FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era
por: Tomizawa, Kento, et al.
Publicado: (2020)

Influence of New FIGO 2018 Staging on Treatment Outcomes in Early-Stage Cervical Cancer: A Single-Center Study
por: Kaur, Satinder, et al.
Publicado: (2022)

Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009
por: Zhang, Yunqiang, et al.
Publicado: (2022)

MRI outcome evaluation in patients with IB2 and IIA2 squamous cervical cancer stages: preliminary results
por: Song, Qingling, et al.
Publicado: (2022)

Treatment Outcome and Prognosis Factors of FIGO 2018 Stage III Cervical Cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam
por: Phung, Huyen Thi, et al.
Publicado: (2021)

Diagnostic Value of (18)F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2021)

Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage
por: Balaya, Vincent, et al.
Publicado: (2020)

Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System
por: Meng, Qingyu, et al.
Publicado: (2022)

The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter
por: Nicolai, Laure, et al.
Publicado: (2023)

Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
por: Huang, Chen-Yu, et al.
Publicado: (2020)

The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy
por: Hwang, Woo Yeon, et al.
Publicado: (2020)

Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
por: Yang, Xi, et al.
Publicado: (2020)

Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer
por: Sznurkowski, Jacek J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qm571tjtbgfs7jqegcpc9obl3b